Loading candles…
Decipher Labs Ltd, incorporated in 1986 and formerly known as Combat Drugs Limited, operates in the pharmaceutical, information technology, healthcare, and life sciences industries. It manufactures and trades pharmaceutical drugs and offers consultancy services primarily focused on healthcare and life sciences. The company serves both Indian and international markets, combining healthcare products with technological consulting. Its business segments include pharmaceutical manufacturing and trading, consultancy services in healthcare and life sciences, and information technology. No information on founders, key management, subsidiaries, or stock listings is available.
This page is a live market overview for DECIPHER LABS LIMITED (DECIPHER) on the BSE. As a listed security, DECIPHER LABS LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for DECIPHER before placing trades on tick2trade.
As of the latest feed, DECIPHER last traded at ₹6.49 on BSE, up ₹0.39 (6.39%) from the previous close of ₹6.1. Today's session range is ₹6.13 – ₹6.5, against a 52-week band of ₹5 – ₹11.38. Traded volume today stands at 10.58K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for DECIPHER in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether DECIPHER is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for DECIPHER LABS LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in DECIPHER. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated DECIPHER option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.